What's on the Horizon for Myasthenia Gravis
Cell-based therapies, broader B-cell targeting, and immune tolerance are all in the works
Stay updated with breaking news from Andreas Meisel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cell-based therapies, broader B-cell targeting, and immune tolerance are all in the works
Proof-of-concept study suggests RNA-engineered cells may be less toxic
2022 FEB 10-- By a News Reporter-Staff News Editor at Insurance Daily News-- New research on Rehabilitation of Speech and Language Disorders- Language Therapy is the subject of a report. According to news reporting out of Berlin, Germany, by NewsRx editors, research stated,“ Impairments to comprehension and production of speech and swallowing disorders are common...
E-Mail Sebastian Lobentanzer of Goethe University, Frankfurt, has been studying small RNA dynamics in various contexts using bioinformatic methods. Recently, small RNAs have become more and more interesting for researchers, primarily because of their extensive regulatory functions. To examine these functions in stroke, Lobentanzer joined Katarzyna Winek of Hebrew University, Jerusalem, to study microRNAs and tRNA fragments in blood samples from ischemic stroke patients collected at Charité, Berlin. "tRNA fragments, which until now were only thought to be debris of the amino acid-transporti...
Sebastian Lobentanzer of Goethe University, Frankfurt, has been studying small RNA dynamics in various contexts using bioinformatic methods. Recently, small RNAs have become more and more interesting for researchers, primarily because of their extensive regulatory functions.